1. Hong Kong Stocks

  2. •

    Finance

  3. •

    Investment managers
Top Eminent Healthcare Group Limited

Top Eminent Healthcare Group Limited

HHKEX:6877
0.10
HKD
+0.00
(-2.00%)
894.65MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.08
0.08
0.2
0.18
0.25
0.21
0.01
- -
- -
0.02
0.09
0.04
0.05
- -
Basic EPS, GAAP
0.02
0.02
0.05
0.02
0.01
0.02
-0.09
-0.04
-0.03
-0.02
- -
0.01
- -
- -
Free Cash Flow per Basic Share
-0.03
0.03
0.03
-0.06
0.08
0.01
-0.06
- -
-0.02
-0.01
- -
-0.01
- -
- -
Dividend per Share
0.02
0.01
0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.19
0.2
0.23
0.25
0.27
0.28
0.19
0.16
0.13
0.11
0.12
0.12
0.12
0.27
Tangible Book Value per Share
0.19
0.19
0.23
0.24
0.25
0.26
0.19
0.16
0.13
0.11
0.12
0.12
0.12
0.26
Basic Weighted Avg Shares
1,828
2,000
2,022
2,033
2,033
2,033
2,033
2,033
2,033
2,033
2,033
2,033
2,033
2,033
Sales/Revenue/Turnover
147
161
403
366
507
433
14
5
5
39
191
86
102
- -
Operating Margin (%)
41.03
32.54
33
17
6.62
11.08
-960.01
-1,539.93
-937.58
-27.06
3.41
-3.3
-11.05
- -
Depreciation Expense
3
3
5
8
13
15
27
15
12
3
- -
- -
- -
- -
Net Income, GAAP
35
35
95
39
27
34
-180
-72
-57
-31
10
11
-7
- -
Effective Tax Rate (%)
30.63
26.45
26.09
28.68
21.89
33.83
- -
- -
- -
- -
11.97
9.94
- -
- -
Profit Margin (%)
23.65
21.81
23.48
10.58
5.4
7.92
-1,322.86
-1,521.58
-1,038.99
-79.36
5.15
13.11
-6.96
- -
Working Capital
375
380
447
476
505
713
377
322
263
230
239
244
241
708
LT Debt
- -
- -
- -
- -
- -
191
11
1
6
- -
- -
- -
- -
197
Total Equity
382
393
465
515
547
572
391
333
269
231
240
244
241
554
Return on Invested Capital (%)
11.27
8.94
21.88
7.51
5.08
8.08
- -
- -
- -
- -
5.43
-1.21
- -
- -
Return on Capital (%)
11.33
9.06
22.41
7.63
5.09
8.1
- -
- -
- -
- -
4.18
4.68
- -
- -
Return on Common Equity (%)
11.31
9.06
22.07
7.9
5.15
6.12
-37.39
-19.79
-18.79
-12.43
4.18
4.68
-2.93
- -

Capital Structure

HKD

•

in mil. unless spec.
Sep'17
Dec'17
Jun'18
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
197
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,033
2,033
2,033
Market Capitalization
1,240
1,240
895

Working Capital

HKD

•

in mil. unless spec.
Sep'17
Dec'17
Jun'18
Total Current Assets
- -
1,355
1,259
Cash, Cash Equivalents & STI
- -
518
1,126
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
850
551
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-5.42%
-5.83%
-1.48%
Free Cash Flow
-230.4%
-180.31%
-58.47%
Net Income, GAAP
-109.44%
-69.08%
-162.74%
Sales/Revenue/Turnover
83.9%
197.33%
18.22%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
191
2024
- -
- -
86
2025
- -
- -
102

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
0.01
2025
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Guang Fei Ji
Full Time Employees
4
Sector
Finance
Industry
Investment managers
Address
Central Plaza Hong Kong Hong Kong
IPO Date
Jul 3, 2013
Website
tehealth.com
Similar Companies
Morgan Stanley (NYSE:MS)
BlackRock, Inc. (NYSE:BLK)
Motilal Oswal Financial Services Limited (NSE:MOTILALOFS)
HDFC Asset Management Co. Ltd. (NSE:HDFCAMC)
Blackstone Inc. (NYSE:BX)
360 One Wam Limited (NSE:360ONE)
Business
Top Eminent Healthcare Group Limited Top Eminent Healthcare Group Limited (6877.HK 6877.HK), an investment holding company incorporated in the Cayman Islands in 2010 and headquartered at Room 5406, 54/F, Central Plaza, 18 Harbour Road, Wan Chai, Hong Kong, principally engages in the sales of healthcare products and related services through its subsidiaries in Australia, Hong Kong, and New Zealand. The company operates in the healthcare products segment, offering nutritional supplements such as molecular tea series (essence drink and instant tea series with no additives and high absorption rates), Ganoderma lucidum spore oil (TRTPRE brand using supercritical carbon dioxide extraction for liver protection, immunity enhancement, and fatigue elimination), Moller's fish oil, and other herbal formulas and functional foods targeting immunity improvement, sleep enhancement, and intestinal health; it also provides personalised health management plans incorporating online Chinese medicine diagnosis, health data analysis, professional nutrition advice, nutritional foods, and medicines. Additional activities encompass product research and development, rigorous quality control meeting international standards, branding and integrated online-offline marketing, and cross-border e-commerce distribution networks to expand global reach. In May 2025, the company changed its name from CLSA Premium Limited, adopted a new stock short name, company logo, website, and amended and restated Memorandum and Articles of Association, marking a strategic shift from prior margin dealing and leveraged foreign exchange trading operations to a primary focus on healthcare; it became a subsidiary of Beijing Tong Ren Tang (Cayman) Limited as of April 2025 and reported an improved unaudited gross profit margin of 42% for the 2025 interim period ended June 30, up from 39% previously, alongside the unaudited interim results announcement in August 2025. These changes support ongoing business expansion in health and wellness markets through innovation and market development partnerships.